Allurion announces findings from new studies on muscle mass maintenance in nearly 20,000 patients and four-year weight loss outcomes at the 2025 annual meeting of the asmbs

Natick, mass.--(business wire)---- $alur--allurion technologies, inc. (nyse: alur), a pioneer in metabolically healthy weight loss, today presented two new abstracts at the american society for metabolic & bariatric surgery (asmbs) 2025 annual meeting. this data include findings from a global, real-world experience evaluating body composition outcomes that demonstrate sustained weight loss, significant fat loss, and preservation of muscle mass with the allurion program and one of the longest real-wor.
ALUR Ratings Summary
ALUR Quant Ranking